Genotropin 12mg Solution for Injection contains Somatropin, a recombinant human growth hormone (36 IU), indicated for the treatment of growth hormone deficiency in both pediatric and adult patients. This medication is utilized to promote linear growth in children with inadequate endogenous growth hormone secretion and to improve metabolic functions in adults with confirmed growth hormone deficiency. Genotropin facilitates protein synthesis, increases muscle mass, reduces adipose tissue, and enhances bone density. The solution is administered via subcutaneous injection, with dosage individualized based on patient weight, clinical response, and serum growth hormone levels. It is essential to monitor patients regularly for therapeutic efficacy and potential adverse effects, including edema, arthralgia, and glucose intolerance. Contraindications include active malignancy, acute critical illness, and hypersensitivity to somatropin or any excipients. Caution is advised in patients with diabetes mellitus or intracranial hypertension. Proper storage conditions must be maintained to preserve drug stability. Genotropin should be prescribed and supervised by healthcare professionals experienced in growth hormone therapy to ensure optimal outcomes and minimize risks. Patient education on injection technique and adherence is critical for treatment success.